Form 4: Astronics Exec Exercises Options, Boosts Holdings
Insider Transaction Report
James Mulato, President of Astronics Test Systems, exercised stock options for common and Class B stock, increasing his direct beneficial ownership.
Summary
- James Mulato, President of Astronics Test Systems, acquired 4,300 shares of $.01 PV Common Stock and 1,387 shares of $.01 PV Class B Stock on October 22, 2025, through the exercise of stock options.
- The exercise price for both classes of stock was $27.72 per share.
- Following these transactions, Mulato directly beneficially owns 36,811.822 shares of Common Stock and 2,453 shares of Class B Stock.
- Mulato holds various unexercised stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates extending up to December 7, 2033.
- He also holds 47,750 target Restricted Stock Units (RSUs) across three tranches, which vest based on Astronics Corp.'s average annual adjusted EBITDA performance for periods ending in 2025, 2026, and 2027, with vesting dates in February 2026, 2027, and 2028 respectively.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. An executive exercising options and increasing their direct ownership signals confidence in the company's future. While routine, it's a positive indicator of insider alignment.
Positives
- The exercise of stock options by a key executive demonstrates continued confidence in the company's future performance and aligns management's interests with shareholders.
- Increased direct beneficial ownership by a senior executive can be viewed positively by investors as a sign of commitment.
Risks
- The vesting of a significant portion of the executive's compensation (Restricted Stock Units) is contingent on Astronics Corp.'s average annual adjusted EBITDA performance, introducing a performance risk for future compensation realization.
- Failure to meet the specified EBITDA targets could result in a lower percentage of RSUs vesting (between 50% and 150% for some tranches, and 75% and 115% for another, of the target number).
Future Outlook
A significant portion of the executive's future compensation, specifically 47,750 target Restricted Stock Units, is tied to Astronics Corp.'s average annual adjusted EBITDA performance over the periods ending December 31, 2025, December 31, 2026, and December 31, 2027. The actual number of units vesting will range from 50% to 150% (or 75% to 115% for one tranche) of the target based on achieving these performance metrics.
Industry Context
Insider transactions, such as the exercise of stock options, are a routine part of executive compensation and ownership structures in publicly traded companies. This filing indicates a standard compensation event where an executive is realizing value from previously granted options and increasing their direct stake in the company, which is generally viewed as a positive signal of alignment with shareholder interests.
Stakeholder Impact
- Shareholders: Increased alignment of executive interests with company performance, as the executive's direct ownership stake has grown. The performance-based vesting of RSUs further ties executive compensation to company financial results (EBITDA).
- Employees: No direct impact mentioned, but executive compensation structures can influence overall company culture and morale.
Next Steps
- Monitoring of Astronics Corp.'s average annual adjusted EBITDA performance for the periods ending December 31, 2025, December 31, 2026, and December 31, 2027, to determine the actual vesting percentage of the executive's Restricted Stock Units.
- Vesting of 11,500 target RSUs on February 23, 2026.
- Vesting of 18,550 target RSUs on February 22, 2027.
- Vesting of 17,700 target RSUs on February 27, 2028.
Key Dates
| Date | Description |
|---|---|
| 12/03/2016 | Date exercisable for stock options that were exercised on 10/22/2025 |
| 12/14/2017 | Date exercisable for certain outstanding stock options |
| 12/12/2018 | Date exercisable for certain outstanding stock options |
| 12/13/2019 | Date exercisable for certain outstanding stock options |
| 12/09/2020 | Date exercisable for certain outstanding stock options |
| 01/22/2022 | Date exercisable for certain outstanding stock options |
| 12/09/2022 | Date exercisable for certain outstanding stock options |
| 12/16/2023 | Date exercisable for certain outstanding stock options |
| 12/07/2024 | Date exercisable for certain outstanding stock options |
| 10/22/2025 | Date of stock option exercise transaction |
| 10/23/2025 | Signature date of the reporting person |
| 12/03/2025 | Expiration date for the exercised stock options |
| February 23, 2026 | Vesting date for 11,500 target Restricted Stock Units (RSUs) based on 2023-2025 EBITDA |
| 12/14/2026 | Expiration date for certain outstanding stock options |
| February 22, 2027 | Vesting date for 18,550 target Restricted Stock Units (RSUs) based on 2024-2026 EBITDA |
| 12/12/2027 | Expiration date for certain outstanding stock options |
| February 27, 2028 | Vesting date for 17,700 target Restricted Stock Units (RSUs) based on 2025-2027 EBITDA |
| 12/13/2028 | Expiration date for certain outstanding stock options |
| 12/09/2029 | Expiration date for certain outstanding stock options |
| 01/22/2031 | Expiration date for certain outstanding stock options |
| 12/09/2031 | Expiration date for certain outstanding stock options |
| 12/16/2032 | Expiration date for certain outstanding stock options |
| 12/07/2033 | Expiration date for certain outstanding stock options |
Keywords
Astronics Corp, ATRO, Insider Transaction, Form 4, Stock Options, Restricted Stock Units, Executive Compensation, Beneficial Ownership, EBITDA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.